Best Practices for Diagnosing Breast Implant-Associated Anaplastic Large Cell Lymphoma
In 2016, the World Health Organization classified BIA-ALCL as a novel lymphoma.
All articles by Susan Moench, PhD, PA-C
Single-Agent Daratumumab May Delay Progression of Smoldering Multiple Myeloma
In this study, 1 of the criteria for defining intermediate- or high-risk smoldering multiple myeloma was clonal bone marrow plasma cells between 10% and less than 60%.
Epidemiologic Evidence of an Association Between Dengue Viral Infection and Leukemia
Risk of a leukemia diagnosis was found to be highest between 3 to 6 years following manifestation of symptoms associated with dengue viral infection.
Younger Age, Consolidation Therapy With Autologous SCT Associated With Improved OS in Patients With Primary CNS Lymphoma
Despite improvements in treatment of CNS lymphoma, median age of people who develop the disease is increasing. Nearly three-quarters of patients included in this population-based study were 60 years or older.
Splenomegaly May Be a Negative Prognostic Factor in Essential Thrombocythemia and Polycythemia Vera
Currently, splenomegaly is not included as a prognostic factor in major prognostic models of Philadelphia-negative myeloproliferative neoplasms.
FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma
The US FDA provided updated information to women with breast implants and their health care providers on the risk of developing a specific type of lymphoma.
- Loading...
Loading...
Loading... 
Loading...